NewsFeed

March 27, 2025

Overcoming Aviophobia with Dr. Rachel Kim's Expertise

Our online seminars provide a safe space for individuals with aviophobia to confront their fears. Led by our team of experts, including Dr. Rachel Kim, an aviation psychologist, we offer a comprehensive understanding of the psychology behind flying and the safety measures in place. Participants learn how to manage anxiety through interactive sessions, guided meditations, and personalized coping strategies. Recent seminars have been held virtually from our offices in New York City, with attendees hailing from across the globe, including London and Tokyo.

https://www.fakti.bg/en/bulgaria/959781-how-to-overcome-the-fear-of-flying-captain-mario-bakalov-in-front-of-fact

March 27, 2025

Queensland Review Led by Professor Ruth Vine

A Queensland review into hormone treatments and puberty blockers for adolescent trans patients will be led by former Victorian chief psychiatrist Professor Ruth Vine, who brings an "independent mind" to the task. The government has maintained a pause on new trans patients under 18 accessing these treatments since January, with the review's report due in November.

https://www.abc.net.au/news/2025-03-27/hormone-therapy-access-children-review-ruth-vine-queensland/105101912

March 27, 2025

Tim Duggan Advocates Boring Jobs for Mental Health

The phrase "there's nothing wrong with having a 'boring' job" is attributed to Tim Duggan, a work columnist. He suggests that having a stable and uneventful job can be beneficial for one's mental health and overall well-being, as it allows individuals to focus on other aspects of their lives without the stress of a demanding career.

https://www.smh.com.au/business/workplace/why-there-s-nothing-wrong-with-having-a-boring-job-20250327-p5ln0b.html

March 27, 2025

WA Government Tackles Indigenous Child Abuse Crisis

The WA government has signed a national 10-year plan to improve the lives of Aboriginal children vulnerable to abuse and neglect. The plan aims to address the over-representation of Aboriginal children in care, with support services such as Counselling and support services (1800 Respect), Bravehearts (1800 272 831) and Child Wise (1800 991 099).

https://www.abc.net.au/news/2025-03-27/indigenous-children-removed-from-families/105099992

March 27, 2025

Dr. Solomon's Stress Survival Kit Launched on MasterClass

MasterClass has launched "In Practice," a new Original Series led by Dr. Alexandra Solomon, offering timely advice for handling stress and anxiety during key moments throughout the year. The series features insights from additional MasterClass instructors and provides a survival kit for managing anxiety in various situations, such as the start of the school year or holidays.

https://www.prnewswire.com/news-releases/masterclass-debuts-in-practice-series-to-help-members-manage-everyday-anxiety-and-thrive-through-uncertainty-302412431.html

March 27, 2025

Jasra Putra Warns of Child Safety Risks During Eid Celebrations

The deputy chair of the KPAI, Jasra Putra, has appealed to regional governments and tourist attraction managers to ensure the comfort and safety of children during Eid al-Fitr homecoming activities. He suggested providing accessible information for parents about potential risks and updating it regularly to protect children from harm. The KPAI recorded 2,057 cases of child rights violations in 2024, including physical, psychological, and sexual violence, with the highest cases in family environment and alternative care clusters.

https://en.antaranews.com/news/350029/kpai-asks-regions-to-ensure-child-friendly-tourist-attractions?utm_source=antaranews&utm_medium=desktop&utm_campaign=popular_right

March 27, 2025

Newport Healthcare Sees Improved Patient Outcomes Nationwide

Newport Healthcare has announced significant improvements in patient well-being across its residential and outpatient programs, with over 4,800 adolescents and young adults surveyed in 2024 showing positive outcomes for depression, anxiety, suicide risk, trauma, and overall well-being. The organization's Transcranial Magnetic Stimulation (TMS) treatment at PrairieCare TMS clinics also showed promising results, with a review by Vanderbilt University's Associate Professor Colin Walsh, MD, MA, confirming the effectiveness of the program.

https://www.prnewswire.com/news-releases/newport-healthcare-releases-2024-outcomes-report-highlighting-significant-patient-improvements-in-mental-health-treatment-302412649.html

March 27, 2025

Rosie Fender Dies After NHS Failures Exposed

A mentally ill woman, Rosie Fender, died in February 2022 after feeling let down by the NHS, which failed to operate normally during the pandemic. Her family claims Southern Health provided little support despite her high needs. An expert witness, Rachael Mejia Olivares, attributes Rosie's deteriorating health to the pandemic and its impact on staff availability.

https://www.dailymail.co.uk/news/article-14543231/Woman-26-scared-outside-showered-eight-hours-day-killed-let-NHS-pandemic.html

March 26, 2025

Antengene Develops Cancer Treatment Breakthrough

The text appears to be a compilation of research summaries from various studies conducted by Antengene, a biotechnology company. The summaries are brief and provide an overview of the research findings, including the objectives, methods, results, and conclusions. There is no specific question or prompt provided in the text that requires a step-by-step solution or a final answer. However, I can extract some key information from the summaries: 1. **ATG-110**: A novel "2+1" LY6G6D x CD3 TCE developed by Antengene for treating microsatellite stable (MSS) colorectal cancer. It demonstrated potent anti-tumor activity in preclinical studies and showed promise as a potential therapeutic agent. 2. **ATG-1144**: A diagnostic antibody developed by Antengene to detect CD24 expression in tumors. The antibody was validated for its specificity, sensitivity, and assay precision, suggesting its potential use in identifying patients with CD24-positive tumors. 3. **Other research summaries**: Brief overviews of other studies conducted by Antengene, including the development of a diagnostic antibody for CD24 targeted therapy (ATG-1144) and the evaluation of ATG-110's binding affinity, T cell activation, and cytokine release. Without further context or clarification on what specific information is being sought, it is challenging to provide a final answer. If you have any additional questions or would like me to elaborate on any of these points, please feel free to ask!

https://www.prnewswire.com/news-releases/antengene-to-present-results-from-four-cutting-edge-preclinical-studies-at-aacr-2025-with-focuses-including-antengagertm-tces-and-synthetic-lethality-302411814.html